It is critical to set the project on the right path from the start. Before we embark on a challenging journey we make the necessary preparations, carefully select appropriate vendors, meticulously map the path and plan for success.
We provide coordination and integration of all product development and study activities by efficient communication among all the parties involved.
We take responsibility for timelines, budget, smooth project progress evaluation and risk management.
We have hands-on experience in selecting, qualifying and overseeing vendors such as Clinical Research Organisations, central and specialised laboratories and CMC providers. While trust and a collaborative approach are key, we ensure expected quality by tracking performance metrics and promoting a quality mindset among project collaborators.
We are driven by results and are focused on ensuring effective issue resolution.
AnRes Clinical as your partner in clinical development will support you in reaching your ambitious goals.
STUDY DESIGN AND MEDICAL WRITING
We have managed clinical investigation and clinical design process in which our team members and consultants calculated statistical sample size, defined study endpoints, wrote the protocol and provided medical expertise. During this process it is critical to carefully set the study endpoints and understand how those will be measured and how supporting data will be collected. This is the best time to consider all practical aspects of patient visits and assessments and operational implications of key examinations, especially if complex centralised measurements are involved. Protocol design is immediately followed by creating project management tools such as risk assessment and study operational plans.
Clinical monitoring is a regulatory mandated sponsor's responsibility of ensuring patient safety and clinical data integrity. Since our CRAs understand the study endpoints, they focus on the data that really matters for safety, efficacy and performance evaluations.
We ensure that CRAs channel all effort towards excellence, understanding the intricate issues of the protocol and the indication, and towards building strong relationships site staff.
We believe focusing on those areas is the basis for outstanding clinical monitoring service.
REGULATORY PATH AND STRATEGY
PRIVATE INVESTOR SOURCING
DATA MANAGEMENT & STATISTICS